Natalizumab and fingolimod differentially impact the alpha-4/beta-1 and alpha-L/beta-2 expression-related subset diversity of T-cells

Andrea Harrer; Katrin Oppermann; J Wanek; Georg Pilz; Peter Wipfler; Johann Sellner; S Afazel; E Haschke-Becher; Eugen Trinka; Jörg Kraus

Natalizumab and fingolimod differentially impact the alpha-4/beta-1 and alpha-L/beta-2 expression-related subset diversity of T-cells

Andrea Harrer, Katrin Oppermann, J Wanek, Georg Pilz, Peter Wipfler, Johann Sellner, S Afazel, E Haschke-Becher, Eugen Trinka, Jörg Kraus

Department of Neurology

Research output: Contribution to journal › published Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	333-333
Journal	MULTIPLE SCLEROSIS
Volume	20
Publication status	Published - 2014
Event	Joint ACTRIMS-ECTRIMS Meeting - Boston, MA Duration: 10 Sept 2014 → 13 Sept 2014

Cite this

Harrer, A., Oppermann, K., Wanek, J., Pilz, G., Wipfler, P., Sellner, J., Afazel, S., Haschke-Becher, E., Trinka, E., & Kraus, J. (2014). Natalizumab and fingolimod differentially impact the alpha-4/beta-1 and alpha-L/beta-2 expression-related subset diversity of T-cells. MULTIPLE SCLEROSIS , 20, 333-333.

Harrer, Andrea ; Oppermann, Katrin ; Wanek, J et al. / Natalizumab and fingolimod differentially impact the alpha-4/beta-1 and alpha-L/beta-2 expression-related subset diversity of T-cells. In: MULTIPLE SCLEROSIS 2014 ; Vol. 20. pp. 333-333.

@article{98a9a58eb9614d888ffbad62f6821db3,

title = "Natalizumab and fingolimod differentially impact the alpha-4/beta-1 and alpha-L/beta-2 expression-related subset diversity of T-cells",

author = "Andrea Harrer and Katrin Oppermann and J Wanek and Georg Pilz and Peter Wipfler and Johann Sellner and S Afazel and E Haschke-Becher and Eugen Trinka and J{\"o}rg Kraus",

year = "2014",

language = "English",

volume = "20",

pages = "333--333",

journal = "MULTIPLE SCLEROSIS ",

issn = "1352-4585",

note = "Joint ACTRIMS-ECTRIMS Meeting ; Conference date: 10-09-2014 Through 13-09-2014",

}

Harrer, A, Oppermann, K, Wanek, J, Pilz, G , Wipfler, P, Sellner, J, Afazel, S, Haschke-Becher, E, Trinka, E & Kraus, J 2014, 'Natalizumab and fingolimod differentially impact the alpha-4/beta-1 and alpha-L/beta-2 expression-related subset diversity of T-cells', MULTIPLE SCLEROSIS , vol. 20, pp. 333-333.

Natalizumab and fingolimod differentially impact the alpha-4/beta-1 and alpha-L/beta-2 expression-related subset diversity of T-cells. / Harrer, Andrea; Oppermann, Katrin; Wanek, J et al.
In: MULTIPLE SCLEROSIS , Vol. 20, 2014, p. 333-333.

Research output: Contribution to journal › published Abstract (Journal) › peer-review

TY - JOUR

T1 - Natalizumab and fingolimod differentially impact the alpha-4/beta-1 and alpha-L/beta-2 expression-related subset diversity of T-cells

AU - Harrer, Andrea

AU - Oppermann, Katrin

AU - Wanek, J

AU - Pilz, Georg

AU - Wipfler, Peter

AU - Sellner, Johann

AU - Afazel, S

AU - Haschke-Becher, E

AU - Trinka, Eugen

AU - Kraus, Jörg

PY - 2014

Y1 - 2014

M3 - published Abstract (Journal)

SN - 1352-4585

VL - 20

SP - 333

EP - 333

JO - MULTIPLE SCLEROSIS

JF - MULTIPLE SCLEROSIS

T2 - Joint ACTRIMS-ECTRIMS Meeting

Y2 - 10 September 2014 through 13 September 2014

ER -

Harrer A, Oppermann K, Wanek J, Pilz G , Wipfler P, Sellner J et al. Natalizumab and fingolimod differentially impact the alpha-4/beta-1 and alpha-L/beta-2 expression-related subset diversity of T-cells. MULTIPLE SCLEROSIS . 2014;20:333-333.